10x Genomics, Inc. (LON:0A88)
London
· Delayed Price · Currency is GBP · Price in USD 11.14
-0.70 (-5.93%)
At close: Feb 21, 2025
10x Genomics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 344.07 | 359.28 | 219.75 | 587.45 | 663.6 | Upgrade
|
| Short-Term Investments | 49.34 | 29.41 | 210.24 | - | - | Upgrade
|
| Cash & Short-Term Investments | 393.4 | 388.7 | 429.98 | 587.45 | 663.6 | Upgrade
|
| Cash Growth | 1.21% | -9.60% | -26.80% | -11.48% | 56.45% | Upgrade
|
| Receivables | 87.86 | 114.83 | 104.21 | 85.25 | 51.21 | Upgrade
|
| Inventory | 83.11 | 73.71 | 81.63 | 59.97 | 29.96 | Upgrade
|
| Prepaid Expenses | 20.02 | 18.79 | 16.58 | 13.9 | 13.03 | Upgrade
|
| Restricted Cash | - | - | 2.63 | 1.03 | 16.57 | Upgrade
|
| Total Current Assets | 584.39 | 596.02 | 635.04 | 747.59 | 774.37 | Upgrade
|
| Property, Plant & Equipment | 309.94 | 344.93 | 359.21 | 230.41 | 119.82 | Upgrade
|
| Goodwill | 4.51 | 4.51 | 4.51 | 4.51 | - | Upgrade
|
| Other Intangible Assets | 15.67 | 16.62 | 22.86 | 25.4 | 22.35 | Upgrade
|
| Other Long-Term Assets | 4.13 | 3.06 | 7.37 | 10.92 | 12.8 | Upgrade
|
| Total Assets | 918.64 | 965.14 | 1,029 | 1,019 | 929.34 | Upgrade
|
| Accounts Payable | 12.91 | 15.74 | 21.6 | 17.35 | 4.71 | Upgrade
|
| Accrued Expenses | 52.07 | 45.98 | 51.9 | 53.27 | 35.09 | Upgrade
|
| Current Portion of Leases | 9.29 | 11.52 | 9.04 | 5.13 | 5.94 | Upgrade
|
| Current Income Taxes Payable | 4.94 | 5.05 | 4.08 | 4.62 | 8.65 | Upgrade
|
| Current Unearned Revenue | 20.66 | 13.15 | 7.87 | 5.34 | 4.47 | Upgrade
|
| Other Current Liabilities | 17.77 | 35.73 | 36.48 | 24.64 | 59.27 | Upgrade
|
| Total Current Liabilities | 117.63 | 127.16 | 130.96 | 110.36 | 118.13 | Upgrade
|
| Long-Term Leases | 73.33 | 83.85 | 86.14 | 76.85 | 57.04 | Upgrade
|
| Long-Term Unearned Revenue | 12.51 | 8.81 | 3.17 | - | - | Upgrade
|
| Other Long-Term Liabilities | 5.03 | 4.28 | 2.98 | 14.05 | 15.1 | Upgrade
|
| Total Liabilities | 208.5 | 224.1 | 223.24 | 201.26 | 190.27 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 2,178 | 2,026 | 1,839 | 1,681 | 1,544 | Upgrade
|
| Retained Earnings | -1,467 | -1,284 | -1,029 | -863.32 | -805.1 | Upgrade
|
| Comprehensive Income & Other | -0.49 | -0.43 | -4.34 | 0.02 | -0.05 | Upgrade
|
| Total Common Equity | 710.13 | 741.04 | 805.74 | 817.57 | 739.07 | Upgrade
|
| Shareholders' Equity | 710.13 | 741.04 | 805.74 | 817.57 | 739.07 | Upgrade
|
| Total Liabilities & Equity | 918.64 | 965.14 | 1,029 | 1,019 | 929.34 | Upgrade
|
| Total Debt | 82.61 | 95.37 | 95.18 | 81.98 | 62.98 | Upgrade
|
| Net Cash (Debt) | 310.79 | 293.33 | 334.81 | 505.47 | 600.63 | Upgrade
|
| Net Cash Growth | 5.95% | -12.39% | -33.76% | -15.84% | 52.27% | Upgrade
|
| Net Cash Per Share | 2.58 | 2.50 | 2.94 | 4.58 | 5.94 | Upgrade
|
| Filing Date Shares Outstanding | 122.3 | 119.17 | 115.36 | 112.84 | 108.75 | Upgrade
|
| Total Common Shares Outstanding | 122.29 | 119.1 | 115.2 | 112.51 | 108.49 | Upgrade
|
| Working Capital | 466.75 | 468.86 | 504.08 | 637.23 | 656.24 | Upgrade
|
| Book Value Per Share | 5.81 | 6.22 | 6.99 | 7.27 | 6.81 | Upgrade
|
| Tangible Book Value | 689.95 | 719.92 | 778.37 | 787.66 | 716.72 | Upgrade
|
| Tangible Book Value Per Share | 5.64 | 6.04 | 6.76 | 7.00 | 6.61 | Upgrade
|
| Land | 36.77 | 36.77 | 36.78 | 36.1 | - | Upgrade
|
| Buildings | 147.09 | 146.04 | - | - | - | Upgrade
|
| Machinery | 97.04 | 96.6 | 76.87 | 62.69 | 41.68 | Upgrade
|
| Construction In Progress | 5.15 | 7.25 | 153 | 52.19 | 19.59 | Upgrade
|
| Leasehold Improvements | 89.57 | 96.41 | 91.52 | 67.53 | 42.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.